Mixed histiocytic disorders: Nature versus nurture?
British Journal of Haematology · 2024
DOI: 10.1111/bjh.19511 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Haematology, 2024. Verfasst von Kenneth McClain und 1 weiteren Autor:innen. Beteiligte Einrichtung: Baylor College of Medicine, Texas Children's Cancer and Hematology Centers, Houston, Texas, USA. Hauptthemen laut MEDLINE: Mutation. Die Arbeit nennt 7 Literaturangaben.
Abstract (Originalsprache)
Histiocytic diseases arise from MAPK mutations in myeloid progenitors. Depending on whether the progenitor follows a dendritic cell or macrophage/monocyte lineage the final histology results in Langerhans cell histiocytosis, Rosai–Dorfman disease or Erdheim–Chester disease. Commentary on: Friedman et al. Mixed histiocytic neoplasms: A multicentre series revealing diverse somatic mutations and responses to targeted therapy. Br J Haematol 2024;205:127–137.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Baylor College of Medicine, Texas Children's Cancer and Hematology Centers, Houston, Texas, USA.
- Wayne State University School of Medicine, Detroit, Michigan, USA.
ORCID-Profile: Kenneth McClain
Zitieren
APA
McClain, K., & Dimitrion, P. (2024). Mixed histiocytic disorders: Nature versus nurture?. British Journal of Haematology. https://doi.org/10.1111/bjh.19511
Vancouver
McClain K, Dimitrion P. Mixed histiocytic disorders: Nature versus nurture?. British Journal of Haematology. 2024. doi:10.1111/bjh.19511
BibTeX
@article{McClain2024,
author = {McClain, Kenneth and Dimitrion, Peter},
title = {Mixed histiocytic disorders: Nature versus nurture?},
journal = {British Journal of Haematology},
year = {2024},
doi = {10.1111/bjh.19511}
}
EUVIMED